Update of histone deacetylase inhibitors
Explore this paper's citation graph
Summary
Histone deacetylase(HDAC)inhibitors contain a functional group that mimics lysine side chain that interacts with the critical HDAC Zinc atom to modulate the gene transcription and expression, inhibit cell proliferation, stimulate cell differentiation, and provocate cell apoptosis.
- Type
- article
- Published
- 2008-01-01
- Cited by
- 0
- References
- 0
- OpenAlex
- https://openalex.org/W2352527331
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:87178790
Keywords
Histone deacetylase, Histone deacetylase 5, HDAC11, Acetylation, Histone deacetylase 2
References
No references recorded for this paper.
Cited by
No citing papers recorded for this paper.
Related papers
- Progress in the research of histone deacetylase inhibitors
- Histone deacetylase inhibitors: discovery and development as anticancer agents
- Isoform-selective histone deacetylase inhibitors.
- Histone deacetylase inhibitors: design, structure-activity relationships and therapeutic implications for cancer.
- Inhibitors of histone deacetylase as antitumor agents: A critical review.
- Histone deacetylase inhibitors
- A Novel Class of Small Molecule Inhibitors of HDAC6
- Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
- Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
- Polymer-assisted, multi-step solution phase synthesis and biological screening of histone deacetylase inhibitors.